DOI:
10.1055/s-00046370
Global Medical Genetics
LinksClose Window
References
Jia Y, Juarez J, Li J. et al.
egf816 exerts anticancer effects in non-small cell lung cancer by irreversibly and selectively targeting primary and acquired activating mutations in the EGF receptor.
Cancer Res 2016;
76 (06) 1591-1602
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.